The burden of weekly intravenous therapy may be significant in some patients with very severe CNS disease.
← all excerpts
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
1
—
—